Antihemophilic globulin (Factor 8) activity of human fibrinogen.

Abstract

Vox SanguinisVolume 11, Issue 1 p. 116-119 Antihemophilic Globulin (Factor VIII) Activity of Human Fibrinogen* Dr. J. T. Sgouris, Corresponding Author Dr. J. T. Sgouris Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this authorDr. L. A. Hyndman, Corresponding Author Dr. L. A. Hyndman Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this authorDr. J. A. Penner, Corresponding Author Dr. J. A. Penner Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this author Dr. J. T. Sgouris, Corresponding Author Dr. J. T. Sgouris Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this authorDr. L. A. Hyndman, Corresponding Author Dr. L. A. Hyndman Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this authorDr. J. A. Penner, Corresponding Author Dr. J. A. Penner Division of Laboratories, Michigan Department of Health, Lansing, Mich. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mich. Division of Laboratories, Michigan Department of Health, Lansing, Mich Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Mick. (USA).Search for more papers by this author First published: January‐February 1966 https://doi.org/10.1111/j.1423-0410.1966.tb04212.x * This work was financed, in part, with funds and material provided under an agreement between the American National Red Cross and the Michigan Department of Health Laboratories.; the Michigan Heart Association and Public Health Service Grant 5M01-FR42–05. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume11, Issue1January‐February 1966Pages 116-119 RelatedInformation